Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1972 3
1973 2
1974 2
1975 1
1976 1
1977 1
1978 3
1979 1
1980 3
1981 3
1982 2
1983 2
1984 3
1985 1
1986 1
1987 2
1988 5
1989 2
1990 5
1991 5
1992 8
1993 9
1994 8
1995 8
1996 10
1997 9
1998 13
1999 6
2000 5
2001 14
2002 12
2003 15
2004 23
2005 13
2006 13
2007 15
2008 20
2009 16
2010 19
2011 27
2012 17
2013 17
2014 20
2015 21
2016 20
2017 21
2018 11
2019 25
2020 36
2021 28
2022 25
2023 20
2024 26
2025 26

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

569 results

Results by year

Filters applied: . Clear all
Page 1
Addition of Metastasis-Directed Therapy to Intermittent Hormone Therapy for Oligometastatic Prostate Cancer: The EXTEND Phase 2 Randomized Clinical Trial.
Tang C, Sherry AD, Haymaker C, Bathala T, Liu S, Fellman B, Cohen L, Aparicio A, Zurita AJ, Reuben A, Marmonti E, Chun SG, Reddy JP, Ghia A, McGuire S, Efstathiou E, Wang J, Wang J, Pilie P, Kovitz C, Du W, Simiele SJ, Kumar R, Borghero Y, Shi Z, Chapin B, Gomez D, Wistuba I, Corn PG. Tang C, et al. Among authors: sherry ad. JAMA Oncol. 2023 Jun 1;9(6):825-834. doi: 10.1001/jamaoncol.2023.0161. JAMA Oncol. 2023. PMID: 37022702 Free PMC article. Clinical Trial.
Addition of Metastasis-Directed Therapy to Systemic Therapy for Oligometastatic Pancreatic Ductal Adenocarcinoma (EXTEND): A Multicenter, Randomized Phase II Trial.
Ludmir EB, Sherry AD, Fellman BM, Liu S, Bathala T, Haymaker C, Medina-Rosales MN, Reuben A, Holliday EB, Smith GL, Noticewala SS, Nicholas S, Price TR, Martin-Paulpeter RM, Perles LA, Lee SS, Lee MS, Smaglo BG, Huey RW, Willis J, Zhao D, Cohen L, Taniguchi CM, Koay EJ, Katz MHG, Wolff RA, Das P, Pant S, Koong AC, Tang C. Ludmir EB, et al. Among authors: sherry ad. J Clin Oncol. 2024 Nov 10;42(32):3795-3805. doi: 10.1200/JCO.24.00081. Epub 2024 Aug 5. J Clin Oncol. 2024. PMID: 39102622 Free PMC article. Clinical Trial.
Mitochondrial Substrate Utilization Regulates Cardiomyocyte Cell Cycle Progression.
Cardoso AC, Lam NT, Savla JJ, Nakada Y, Pereira AHM, Elnwasany A, Menendez-Montes I, Ensley EL, Petric UB, Sharma G, Sherry AD, Malloy CR, Khemtong C, Kinter MT, Tan WLW, Anene-Nzelu CG, Foo RS, Nguyen NUN, Li S, Ahmed MS, Elhelaly WM, Abdisalaam S, Asaithamby A, Xing C, Kanchwala M, Vale G, Eckert KM, Mitsche MA, McDonald JG, Hill JA, Huang L, Shaul PW, Szweda LI, Sadek HA. Cardoso AC, et al. Among authors: sherry ad. Nat Metab. 2020 Feb;2(2):167-178. Epub 2020 Feb 20. Nat Metab. 2020. PMID: 32617517 Free PMC article.
Review and consensus recommendations on clinical APT-weighted imaging approaches at 3T: Application to brain tumors.
Zhou J, Zaiss M, Knutsson L, Sun PZ, Ahn SS, Aime S, Bachert P, Blakeley JO, Cai K, Chappell MA, Chen M, Gochberg DF, Goerke S, Heo HY, Jiang S, Jin T, Kim SG, Laterra J, Paech D, Pagel MD, Park JE, Reddy R, Sakata A, Sartoretti-Schefer S, Sherry AD, Smith SA, Stanisz GJ, Sundgren PC, Togao O, Vandsburger M, Wen Z, Wu Y, Zhang Y, Zhu W, Zu Z, van Zijl PCM. Zhou J, et al. Among authors: sherry ad. Magn Reson Med. 2022 Aug;88(2):546-574. doi: 10.1002/mrm.29241. Epub 2022 Apr 22. Magn Reson Med. 2022. PMID: 35452155 Free PMC article. Review.
A Frequency-Selective pH-Responsive paraCEST Agent.
Ratnakar SJ, Chirayil S, Funk AM, Zhang S, Queiró JF, Geraldes CFGC, Kovacs Z, Sherry AD. Ratnakar SJ, et al. Among authors: sherry ad. Angew Chem Int Ed Engl. 2020 Nov 23;59(48):21671-21676. doi: 10.1002/anie.202008888. Epub 2020 Oct 6. Angew Chem Int Ed Engl. 2020. PMID: 32726500 Free PMC article.
Metastases-Targeting Radiotherapy and ADT-Reply.
Sherry AD, Corn PG, Tang C. Sherry AD, et al. JAMA Oncol. 2023 Nov 1;9(11):1587-1588. doi: 10.1001/jamaoncol.2023.3631. JAMA Oncol. 2023. PMID: 37707804 No abstract available.
Genomic and Epigenomic Analysis of Plasma Cell-Free DNA Identifies Stemness Features Associated with Worse Survival in Lethal Prostate Cancer.
Chauhan PS, Alahi I, Sinha S, Ledet EM, Mueller R, Linford J, Shiang AL, Webster J, Greiner L, Yang B, Ni G, Dang HX, Saha D, Babbra RK, Feng W, Harris PK, Qaium F, Duose DY, Alexander SE, Sherry AD, Jaeger EB, Miller PJ, Caputo SA, Orme JJ, Lucien F, Park SS, Tang C, Pachynski RK, Sartor O, Maher CA, Chaudhuri AA. Chauhan PS, et al. Among authors: sherry ad. Clin Cancer Res. 2025 Jan 6;31(1):151-163. doi: 10.1158/1078-0432.CCR-24-1658. Clin Cancer Res. 2025. PMID: 39177583 Free PMC article.
Nephrogenic systemic fibrosis: a chemical perspective.
Rofsky NM, Sherry AD, Lenkinski RE. Rofsky NM, et al. Among authors: sherry ad. Radiology. 2008 Jun;247(3):608-12. doi: 10.1148/radiol.2473071975. Radiology. 2008. PMID: 18487530 No abstract available.
Adding Metastasis-Directed Therapy to Standard-of-Care Systemic Therapy for Oligometastatic Breast Cancer (EXTEND): A Multicenter, Randomized Phase 2 Trial.
Reddy JP, Sherry AD, Fellman B, Liu S, Bathala T, Haymaker C, Cohen L, Smith BD, Ramirez D, Shaitelman SF, Chun SG, Medina-Rosales M, Teshome M, Brewster A, Barcenas CH, Reuben A, Ghia AJ, Ludmir EB, Weed D, Shah SJ, Mitchell MP, Woodward WA, Gomez DR, Tang C. Reddy JP, et al. Among authors: sherry ad. Int J Radiat Oncol Biol Phys. 2025 Mar 15;121(4):885-893. doi: 10.1016/j.ijrobp.2024.10.030. Epub 2024 Oct 30. Int J Radiat Oncol Biol Phys. 2025. PMID: 39486645 Free PMC article. Clinical Trial.
569 results